| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
phenotype | 0.320 | None | 1.000 | 3 | 0 | 2011 | 2018 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.100 | None | 0.952 | 21 | 1 | 1996 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.100 | None | 0.941 | 17 | 0 | 2006 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2003 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.090 | None | 1.000 | 9 | 0 | 1992 | 2019 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 2017 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2008 | 2019 | ||||||||
|
CD68 molecule | 0.408 | 0.808 | 1.4E-06 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2017 | ||||||||
|
C-X-C motif chemokine ligand 10 | 0.378 | 0.885 | 0.37 |
|
phenotype | 0.040 | None | 0.750 | 4 | 0 | 2003 | 2018 | ||||||||
|
C-X-C motif chemokine ligand 9 | 0.462 | 0.808 | 2.9E-03 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2018 | ||||||||
|
serpin family H member 1 | 0.545 | 0.769 | 2.8E-02 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2013 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2018 | ||||||||
|
CD14 molecule | 0.392 | 0.885 | 4.9E-05 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2017 | ||||||||
|
caspase 1 | 0.413 | 0.885 | 3.5E-05 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2017 | ||||||||
|
peripherin 2 | 0.551 | 0.500 | 0.12 |
|
phenotype | 0.020 | None | < 0.001 | 2 | 0 | 2017 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2017 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2008 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2014 | ||||||||
|
microRNA 223 | 0.433 | 0.808 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2018 | |||||||||
|
Hypercalciuria, absorptive, 1 | 0.633 | 0.654 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
forkhead box P3 | 0.368 | 0.846 | 0.99 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2017 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
15-hydroxyprostaglandin dehydrogenase | 0.516 | 0.731 | 1.4E-05 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2014 |